This webinar is the second in a three part series that will provide an overview of how cutting-edge genomic technologies based on next-generation sequencing (NGS) are streamlining in vitro fertilization research workflows*.
Luis A. Alcaraz, cofounder of Bioarray and Journey Genomics, accredited diagnostic and research labs based in Alicante, Spain, will review how his teams use advanced genomic techniques for carrier screening research as well as for preimplantation genetic testing (PGT) in embryos for both aneuploidies (PGT-A) and monogenic disorders (PGT-M).
These technologies deliver greater efficiency to Bioarray and Journey Genomics, allowing faster delivery of meaningful results and reports for geneticists and researchers, which in turn is increasing their customer outcomes.
In this webinar you will learn:
- How to study PGT-A and PGT-M with NGS
- How expanded carrier screening with NGS screens for 420 genes in a single assay
- How new molecular techniques are improving workflows at Bioarray and Journey Genomics
*For research use only. Not for use in diagnostic procedures.